List of insiders holdings for CRISPR Therapeutics AG:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
GLAXOSMITHKLINE PLC
10% Owner		2020-07-10 17:26:333,310,627
0		3,310,627Form 13D
BAYER AKTIENGESELLSCHAFT
Bayer Global Investments B.V.
10% Owner		2020-02-04 16:19:062,954,775
0		2,954,775Form 13D
CELGENE CORP
10% Owner		2018-02-08 16:25:562,800,772
0		2,800,772Form 13D
Vertex Pharmaceuticals (Europe) Ltd
VERTEX PHARMACEUTICALS INC
10% Owner		2020-02-13 16:05:282,690,470
0		2,690,470Form 13G
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner		2021-02-16 07:33:521,344,010
0		1,344,010Form 13D
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Ventures IV LLC
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner		2021-02-16 07:33:521,344,010
0		1,344,010Form 13D
EMSTER KURT VON
Director		2019-01-18 16:32:230
1,171,268		1,171,268Form 4/A
Lundberg Sven Ante
Chief Scientific Officer		2017-02-10 14:16:28505,217
505,617		1,010,834Form 4
Hadley Harbor Master Investors (Cayman) L.P.
10% Owner		2016-10-24 14:58:09744,380
0		744,380Form 4
Kulkarni Samarth
Chief Executive Officer		2023-03-14 17:47:12670,377
0		670,377Form 4
Novak Rodger
President		2021-07-01 17:43:55573,007
0		573,007Form 4
Prasad Raju
Chief Financial Officer		2023-03-14 17:50:19140,000
0		140,000Form 4
TOMSICEK MICHAEL JOHN
Chief Financial Officer		2021-08-10 20:00:31132,891
0		132,891Form 4
KASINGER JAMES R.
General Counsel and Secretary		2023-03-14 17:45:39121,344
0		121,344Form 4
Versant Venture Capital V L.P.
Versant Ventures V LLC
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner		2018-04-26 16:44:030
115,645		115,645Form 4
Subramanian Kala
See Remarks		2017-06-19 16:05:3385,000
0		85,000Form 4
Dylan-Hyde Tyler
Chief Legal Officer		2018-01-18 17:38:3667,104
0		67,104Form 4
Morrow Phuong Khanh
Chief Medical Officer		2023-03-14 17:44:0766,620
0		66,620Form 4
Ho Tony W
Executive VP, Head of R&D		2021-12-07 20:00:1965,697
0		65,697Form 4
CAGNONI PABLO J
Director		2019-11-21 16:07:4363,833
0		63,833Form 4
Woiwode Thomas
Director		2018-06-15 21:39:450
30,000		30,000Form 4
Fardis Maria
Director		2022-06-10 17:37:4824,000
0		24,000Form 4
Smith Brendan
Chief Financial Officer		2023-02-22 17:41:4116,547
0		16,547Form 4
COLES N ANTHONY
Director		2017-06-02 16:30:1915,000
0		15,000Form 4
Klein Lawrence Otto
CBO & COO		2022-08-18 17:36:0212,500
0		12,500Form 4
Treco Douglas A
Director		2022-06-10 17:44:4612,000
0		12,000Form 4
Behbahani Ali
Director		2022-06-10 17:46:3012,000
0		12,000Form 4
High Katherine A
Director		2022-06-10 17:43:0812,000
0		12,000Form 4
Greene John
Director		2022-06-10 17:41:5412,000
0		12,000Form 4
George Simeon
Director		2022-06-10 17:39:5512,000
0		12,000Form 4
Fleming Harold Edward
Director		2022-06-10 17:36:5712,000
0		12,000Form 4
Bolzon Bradley J PhD
Director		2022-06-10 17:35:0912,000
0		12,000Form 4